TABLE 2

Uptake (%ID/g) of 111In-RGD2 Plus 50 μg of RGD2 in FaDu Xenografts in Mice Treated with Sorafenib

FaDu
Time after treatment (d)ControlSorafenib
20.44 ± 0.210.32 ± 0.09
90.40 ± 0.040.50 ± 0.12
190.19 ± 0.010.28 ± 0.03*

  • ↵* P ≤ 0.05.